This federal contract award SPE2DB22D1106|SPE2DB25FDPX1 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,058.04 firm fixed-price delivery order is for the drug Ganirelix Acetate 250 mcg/0.5 mL, with a completion date of December 11, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This award demonstrates AmerisourceBergen's role as a key vendor for federal healthcare programs, particularly within the military and veterans' healthcare systems, through its extensive distribution capabilities and broad portfolio of medical commodities.
Generated 3/11/25, 9:47 AM